Associated Risk Factors of Chronic Kidney Disease in Jalalabad Afghanistan
DOI:
https://doi.org/10.53555/bp.v6i8.1391Keywords:
Chronic renal failure, Risk factors, Hypertension, Diabetes mellitus, AgeAbstract
BACKGROUND: Chronic kidney disease is a global health problem, affecting the majority of countries in the world. Its prevalence is approximately 10% and is associated mainly with Diabetes mellitus and hypertension. It is a condition in which the kidneys function or structural changes or GFR is reduced from / 1.7 sq.m 60ml / min for three months or longer and it is the leading cause of death in hospitals after cardiovascular disease, tuberculosis and malaria.
OBJECTIVES: Determine the Risk factors of chronic kidney disease, such as age, sex, Family history, Drug use, smoking, and socioeconomic status, and concurrent Disease, such as hypertension and Diabetes mellitus associated with chronic renal insufficiency.
METHODS: This is a Descriptive cross-sectional study conducted in Nishtar National Kidney and Rukhan Teaching Hospitals Jalalabad, Afghanistan, and was performed on 103 patients under Hemodialysis Departments from March through December 2019 and collect data from Individual health histories, Demographic characteristics (age, sex, Body weight, Height, Place of Residence and others factors) on social conditions and risk factors. A physical examination was performed, along with laboratory tests (blood chemistry) to measure renal function and detect markers for renal damage, the history of certain diseases and the presence or absence of certain habits have been investigated.
RESULT: The study included a total of 103 patients with chronic renal insufficiency. 61 (59.2%) were Males and 42 (40.8%) females with no significant difference in the number of gender. The majority of the patients were men and residents of Nangarhar province with an average age of (Mean± SD) 40.53 ± 18.06 years. The majority of patients were married, illiterate and of mid-level socioeconomic status. Three out of every four patients with renal insufficiency had a history of high blood pressure, as well as kidney stones, Diabetes mellitus and Dyslipidemia. In terms of habits, the use of other types of tobacco (such as naswar), smoking and the use of certain drugs have been found to be very addictive.
CONCLUSIONS: Chronic kidney Disease is alarming in communities, among both young and older age, men and women. Health services must be properly aligned to manage increased burden of chronic kidney disease, and preventive strategies should be implemented in a practical way.
Downloads
References
2: United States Renal Data System (USRDS). 2004 annual report. Am J Kidney Dis. 2005; 45(Suppl. 1).
3. Ansell D, Fest T, editors. UK renal registry re-port 2004. Bristol: UK Renal Registry; 2004.
4. Barsoum RS. Chronic Kidney Disease in the Developing World. New Engl J Med. 2006 Mar 9; 354(10):997–9.
5. Soderland P, Lovekar S, Weiner DE, Brooks DR, Kaufman JS. Chronic Kidney Disease Associated With Environmental Toxins and Exposures. Adv Chronic Kidney Dis. 2010 May; 17(3):254–64.
6. Takahashi S, Okada K, Yanai M. The Kidney Early Evaluation Program (KEEP) of Japan: results from the initial screening period. Kidney Int Suppl. 2010 Mar ;( 116): S17-23.
7. Herrera Valdés R, Almaguer López M. Estudio epidemiológico en la comunidad de la enferme-dad renal crónica, enfermedad cardiocerebro-vascular, hypertensions arterial y diabetes mellitus. Estudio ISYS, Isla de la Juventud, Cuba. Havana: Editorial Ciencias Médicas; 2008. p. 41–9. Spanish.
8: Fauci Anthony S MD. Longo, Dan L.MD, Kasper, Dennis L MD, Hauser Stephen L MD, Jameson J. Larry MD.PhD, Loscalzo, Joseph MD.PhD (2012) Harrison’s Principles of Internal Medicine 18th Edition, Mc Graw Hill Company, New York. Pp; 333,336.
9. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038–2047.
10. Suleymanlar G, Utas C, Arinsoy T et al. A population-based survey of Chronic Renal Disease in Turkey—the CREDIT study. Nephrol Dial Transplant 2011; 26: 1862–1871.
11. McClellan WM, Flanders WD. Risk factors for progressive chronic kidney disease. J Am Soc Nephrol 2003; 14: S65–S70.
12. Versino, E.; Piccoli, G.B. Chronic Kidney Disease: The Complex History of the Organization of Long-Term Care and Bioethics. Why Now, More Than Ever, Action is needed. Int. J. Environ. Res. Public Health 2019, 16, 785. [CrossRef] [PubMed]
13. Liyanage, T.; Ninomiya, T.; Jha, V.; Neal, B.; Patrice, H.M.; Okpechi, I.; Zhao, M.H.; Lv, J.; Garg, A.X.; Knight, J.; et al. Worldwide access to treatment for end-stage kidney disease: A systematic review. Lancet 2015, 385, 1975–1982. [CrossRef]
14. Wang, F.; Yang, C.; Long, J.; Zhao, X.; Tang,W.; Zhang, D.; Bai, K.; Su, Z.; Gao, B.; Chu, H.; et al. Executive summary for the 2015 Annual Data Report of the China Kidney Disease Network (CK-NET). Kidney Int. 2019, 95, 501–505. [CrossRef] [PubMed]
15. Available online: http://www.stats.gov.cn/tjsj/pcsj/rkpc/6rp/indexch.htm (accessed on 5 October 2019).
16. Coresh, J.; Selvin, E.; Stevens, L.A.; Manzi, J.; Kusek, J.W.; Eggers, P.; Van Lente, F.; Levey, A.S. Prevalence of chronic kidney disease in the United States. JAMA 2007, 298, 2038–2047. [CrossRef]
17. Duan, J.; Wang, C. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: A cross-sectional survey. Sci. Rep. 2019, 9, 10408. [CrossRef]
18. Levey, A.S.; Coresh, J. Chronic kidney disease. Lancet 2012, 379, 165–180. [CrossRef]
19. Arora, P.; Vasa, P.; Brenner, D.; Iglar, K.; McFarlane, P.; Morrison, H.; Badawi, A. Prevalence estimates of chronic kidney disease in Canada: Results of a nationally representative survey. CMAJ 2013, 185, E417–E423.[CrossRef]
20.Lee, S.W.; Kim, Y.C.; Oh, S.W.; Koo, H.S.; Na, K.Y.; Chae, D.W.; Kim, S.; Chin, H.J. Trends in the prevalence of chronic kidney disease, other chronic diseases and health-related behaviors in an adult Korean population: Data from the Korean National Health and Nutrition Examination Survey (KNHANES). Nephrol. Dial.Transplant. 2011, 26, 3975–3980. [CrossRef]
21. Zhang, L.; Wang, F.; Wang, L.; Wang, W.; Liu, B.; Liu, J.; Chen, M.; He, Q.; Liao, Y.; Yu, X.; et al. Prevalence of chronic kidney disease in China: A cross-sectional survey. Lancet 2012, 379, 815–822. [CrossRef]
22. Eknoyan, G.; Levin, N.W. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am. J. Kidney Dis. 2002, 39, S1–S266.
23. Ko¨ ttgen A, Glazer NL, Dehghan A et al. Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 2009; 41: 712–717.
24. Pollak MR, Genovese G, Friedman DJ. APOL1 and kidney disease. Curr Opin Nephrol Hypertens 2012; 21: 179–182.
25. Su SL, Lu KC, Lin YF et al. Gene polymorphisms of angiotensin-converting enzyme and angiotensin II type 1 receptor among chronic kidney disease patients in a Chinese population. J Renin Angiotensin Aldosterone Syst 2012; 13: 148–154.
26. Song EY, McClellan WM, Mc Clellan a et al. Effect of community characteristics on familial clustering of end-stage renal disease. Am J Nephrol 2009; 30: 499–504?
27. Iseki K. Factors influencing the development of end-stage renal disease. Clin Exp Nephrol 2005; 9: 5–14.
28. Takamatsu N, Abe H, Tominaga T et al. Risk factors for chronic kidney disease in Japan: a community-based study. BMC Nephrol 2009; 10.
29. Mackenzie HS, Lawler EV, Brenner BM. Congenital oligo nephropathy: the fatal flaw in essential hypertension? Kidney Int Suppl 1996; 55:S30–S34.
30. Luyckx VA, Brenner BM. The clinical importance of nephron mass. J Am Soc Nephrol 2010; 21:898–910.
31. Vikse BE, Irgens LM, Leivestad T et al. Low birth weight increases risk for end-stage renal disease. J Am Soc Nephrol 2008; 19: 151–157.
32. Orantes CM, Herrera R, Almaguer M, Brizuela EG, Hernández CE, Bayarre H, et al. Chronic kidney disease and associated risk factors in the Bajo Lempa region of El Salvador: Nefrolempa study, 2009. MEDICC Rev [Internet]. 2011 Oct [cited 2013 Sep 14]; 13(4):14-22 Available from: http://www.medicc.org/mediccreview/index. .php? Issue=18&id=221&a=VA
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 International Journal For Research In Biology & Pharmacy (ISSN: 2208-2093)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
In consideration of the journal, Green Publication taking action in reviewing and editing our manuscript, the authors undersigned hereby transfer, assign, or otherwise convey all copyright ownership to the Editorial Office of the Green Publication in the event that such work is published in the journal. Such conveyance covers any product that may derive from the published journal, whether print or electronic. Green Publication shall have the right to register copyright to the Article in its name as claimant, whether separately
or as part of the journal issue or other medium in which the Article is included.
By signing this Agreement, the author(s), and in the case of a Work Made For Hire, the employer, jointly and severally represent and warrant that the Article is original with the author(s) and does not infringe any copyright or violate any other right of any third parties, and that the Article has not been published elsewhere, and is not being considered for publication elsewhere in any form, except as provided herein. Each author’s signature should appear below. The signing author(s) (and, in
